Simcere Pharmaceutical Co. Ltd. has described stachybotrys microspore triprenyl phenols (SMTPs) acting as plasminogen activators reported to be useful for the treatment of thromboembolism.

Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have divulged pentacyclic derivatives reported to be useful for the treatment of autoimmune disease.

Hangzhou Raygene Pharmaceutical Co. Ltd. has identified benzotriazine dioxide compounds reported to be useful for the treatment of cancer.

Scientists at Apichope Bio Pharmaceutical Co. Ltd., Apichope Pharmaceutical Co. Ltd., Guangzhou Lianrui Pharmaceutical Co. Ltd. and Guangzhou Runlin Pharmaceutical Technology Co. Ltd. have synthesized sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers potentially useful for the treatment of pain, arrhythmia, cough, multiple sclerosis, urinary incontinence and Charcot-Marie-Tooth disease.

Scinnohub Pharmaceutical Co. Ltd. has disclosed compounds reported to be useful for the treatment of cancer and inflammatory diseases.

Sichuan Credit Pharmaceutical Co. Ltd. has described cocrystals of tizanidine and meloxicam reported to be useful for the treatment of pain.

Haisco Pharmaceutical Group Co. Ltd. has divulged cyclic GMP-AMP synthase (MB21D1; cGAS) inhibitors reported to be useful for the treatment of inflammatory, renal, psychiatric, cardiovascular, eye, respiratory and metabolic disorders, as well as cancer.

Hangzhou Baicreat Pharma-Tech Co. Ltd. has identified DNA polymerase θ (POLθ) inhibitors reported to be useful for the treatment of cancer.

Nanjing Nuoyuan Medical Devices Co. Ltd. has synthesized heptamethine cyanine near infrared (NIR) dyes reported to be useful for diagnosis of cancer.

Shanghai Apeiron Biotechnology Co. Ltd. has disclosed proteolysis targeting chimeras (PROTACs) reported to be useful for the treatment of cancer.